Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
1.880
-0.150 (-7.39%)
At close: May 8, 2026, 4:00 PM EDT
2.060
+0.180 (9.57%)
After-hours: May 8, 2026, 4:46 PM EDT
Indaptus Therapeutics Employees
Indaptus Therapeutics had 5 employees as of December 31, 2025. The number of employees decreased by 2 or -28.57% compared to the previous year.
Employees
5
Change (1Y)
-2
Growth (1Y)
-28.57%
Revenue / Employee
n/a
Profits / Employee
-$4,169,783
Market Cap
4.22M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 5 | -2 | -28.57% | 5 | 0 |
| Dec 31, 2024 | 7 | 0 | - | 7 | 0 |
| Dec 31, 2023 | 7 | 1 | 16.67% | 7 | 0 |
| Dec 31, 2022 | 6 | 1 | 20.00% | 6 | 0 |
| Dec 31, 2021 | 5 | 3 | 150.00% | 5 | 0 |
| Jun 30, 2021 | 5 | - | - | 5 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AIM ImmunoTech | 21 |
| BiomX | 20 |
| VivoSim Labs | 14 |
| Azitra | 13 |
| Revelation Biosciences | 9 |
| Galmed Pharmaceuticals | 6 |
| Alzamend Neuro | 6 |
| 60 Degrees Pharmaceuticals | 3 |
INDP News
- 4 months ago - Indaptus Therapeutics enters $6M securities purchase agreement with David Lazar - TheFly
- 4 months ago - Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - GlobeNewsWire
- 6 months ago - Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit - GlobeNewsWire
- 6 months ago - Indaptus Therapeutics reports Q3 EPS ($2.98) vs ($9.04) last year - TheFly
- 6 months ago - Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 8 months ago - Indaptus Therapeutics provides update on INDP-D101 clinical trial - TheFly
- 8 months ago - Indaptus Therapeutics Provides Clinical Update - GlobeNewsWire
- 8 months ago - Indaptus Therapeutics to Present at the H.C. Wainwright 27ᵗʰ Annual Global Investment Conference - GlobeNewsWire